SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Biltmore Family Office LLC

Biltmore Family Office LLC lifted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.2% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,147 shares of the exchange traded fund’s stock after purchasing an additional 725 shares during the period. Biltmore Family Office LLC’s holdings in SPDR S&P Biotech ETF were worth $1,682,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in XBI. Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $396,844,000. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after acquiring an additional 730,000 shares in the last quarter. Mirae Asset Securities USA Inc. acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter worth approximately $55,626,000. Jane Street Group LLC grew its holdings in SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after acquiring an additional 391,333 shares in the last quarter. Finally, Baymount Management LP acquired a new position in SPDR S&P Biotech ETF during the 1st quarter worth approximately $34,160,000.

SPDR S&P Biotech ETF Stock Up 0.2 %

NYSEARCA XBI opened at $98.10 on Wednesday. SPDR S&P Biotech ETF has a 52 week low of $63.80 and a 52 week high of $103.52. The stock has a market capitalization of $7.48 billion, a PE ratio of 11.47 and a beta of 1.11. The firm has a 50 day moving average of $97.97 and a two-hundred day moving average of $93.87.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.